0001213900-23-083868.txt : 20231106 0001213900-23-083868.hdr.sgml : 20231106 20231106160322 ACCESSION NUMBER: 0001213900-23-083868 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20231031 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231106 DATE AS OF CHANGE: 20231106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Augmedix, Inc. CENTRAL INDEX KEY: 0001769804 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 833299164 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40890 FILM NUMBER: 231379916 BUSINESS ADDRESS: STREET 1: 111 SUTTER STREET, SUITE 1300 CITY: SAN FRANCISC STATE: CA ZIP: 94104 BUSINESS PHONE: 561-989-2208 MAIL ADDRESS: STREET 1: 111 SUTTER STREET, SUITE 1300 CITY: SAN FRANCISC STATE: CA ZIP: 94104 FORMER COMPANY: FORMER CONFORMED NAME: Malo Holdings Corp DATE OF NAME CHANGE: 20190305 8-K 1 ea187793-8k_augmedix.htm CURRENT REPORT
0001769804 false 0001769804 2023-10-31 2023-10-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): October 31, 2023

 

AUGMEDIX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40890   83-3299164

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer
Identification No.)

 

111 Sutter Street, Suite 1300, San Francisco, California 94104

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (888) 669-4885

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   AUGX   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement

 

On October 31, 2023 (the “Execution Date”), Augmedix Operating Corp., a Delaware corporation (the “Sublessee”), a wholly-owned subsidiary of Augmedix, Inc., a Delaware corporation (the “Company”), entered into an amendment (the “Amendment”) to an office sublease (the “Original Sublease”) with Turo, Inc., a Delaware corporation (the “Sublessor”), for the property located at 111 Sutter Street, Suite 1300, San Francisco, California, containing approximately 12,936 rentable square feet. The Amendment extends, among other things, the term of the original sublease until January 31, 2027 (the “Termination Date”), unless earlier terminated.

 

Beginning on the later of (i) the Execution Date and (ii) the date the landlord delivers consent to the Amendment (the “Commencement Date”), the monthly rent shall be $61,446.00 (the “Base Rent”) and will increase three percent (3%) each year until the Termination Date, with such Base Rent being abated for the first two (2) months following the Commencement Date and for the thirteenth (13th) and fourteenth (14th) months following the Commencement Date, which abatement amounts are to be calculated at a Base Rent of $57.00 per rentable square foot. The Sublessee will continue to be required to pay certain operating expenses, taxes and other charges as set forth in the Original Sublease. The Amendment terminates the right of the Sublessee to extend the term of the Original Sublease.

 

The Amendment is furnished as Exhibit 10.1 to this current report on Form 8-K and is incorporated herein by reference. The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
   
10.1   Amendment to Sublease by and between, Augmedix Operating Corp. and Turo Inc., dated October 31, 2023.
     
104   Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.

  

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AUGMEDIX, INC.
     
Dated: November 6, 2023 By: /s/ Paul Ginocchio
    Paul Ginocchio
    Chief Financial Officer

 

 

2

 

 

 

EX-10.1 2 ea187793ex10-1_augmedix.htm AMENDMENT TO SUBLEASE BY AND BETWEEN, AUGMEDIX OPERATING CORP. AND TURO INC., DATED OCTOBER 31, 2023

Exhibit 10.1

 

AMENDMENT TO SUBLEASE

 

THIS AMENDMENT TO SUBLEASE (“Amendment”) is entered into as of October 30, 2023 (the “Amendment Effective Date”), by and between TURO INC., a Delaware corporation (“Sublessor”), and AUGMEDIX OPERATING CORP., a Delaware corporation (“Sublessee”) with reference to the following facts:

 

A.Sublessor and Sublessee are parties to that certain Sublease dated as of December 15, 2020 (the “Original Sublease”), pursuant to which Sublessor subleases to Sublessee space containing approximately 12,936 rentable square feet (the “Subleased Premises”) on the thirteen (13th) floor (Suite 1300) of the building located at 111 Sutter Street, San Francisco, California. The Original Sublease, as amended hereby, may be referred to herein as the “Sublease”.

 

B.Sublessor and Sublessee desire to enter into this Amendment to extend the Term and to provide for certain other matters, all on the following terms and conditions.

 

NOW, THEREFORE, in consideration of the above recitals which by this reference are incorporated herein, the mutual covenants and conditions contained herein and other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Sublessor and Sublessee agree as follows:

 

1. Extension of Term. The Term is extended until January 31, 2027 (the “Sublease Expiration Date”), unless earlier terminated as set forth in the Sublease.

 

2. Base Rent for Subleased Premises. From and after the Amendment Commencement Date (as hereinafter defined) and for the remainder of the Term, Sublessee shall pay Sublessor monthly installments of Base Rent for the Subleased Premises as follows:

 

Period  Annual Rent Per Rentable Square Foot   Annual Rent   Monthly Rent 
Amendment Commencement Date to October 31, 2024  $57.00   $737,352.00   $61,446.00 
November 1, 2024 to October 31, 2025  $58.71   $759,472.56   $63,289.38 
November 1, 2025 to October 31, 2026  $60.47   $782,256.74   $65,188.06 
November 1, 2026 to Sublease Expiration Date  $62.29   $805,724.44   $67,143.70 

 

 

 

 

As used herein, the “Amendment Commencement Date” shall mean the later of (i) the date this Amendment has been fully executed by both Sublessor and Sublessee and (ii) the date the Consent (as defined below) has been executed by Landlord and delivered to Sublessor and Sublessee. Base Rent for any partial month during the Term shall be prorated based on the number of days in the applicable calendar month. All such Base Rent shall be payable by Sublessee in accordance with the terms of the Sublease. Notwithstanding the foregoing and provided that Sublessee is not in default under the Sublease, the Base Rent for the Subleased Premises shall be abated for the first two (2) months following the Amendment Commencement Date and for the thirteenth (13th) and fourteenth (14th) months following the Amendment Commencement Date, which abatement amounts shall be calculated using Base Rent at $57.00 per rentable square foot. Upon the occurrence of a subsequent default by Sublessee, and subject to all applicable notice and cure periods under the Sublease, Sublessor may, at its option, and in addition to any other rights and remedies Sublessor may have in connection with such default by Sublessee, terminate this rent abatement provision, whereupon the Base Rent for the Subleased Premises provided for above will be due and payable for such period, to the extent already occurred, and thereafter in accordance with the terms of this Amendment.

 

3. Additional Rent for Subleased Premises. From and after the Amendment Commencement Date and for the remainder of the Term, Sublessee shall continue to pay Sublessor Additional Rent as set forth in the Sublease.

 

4. Termination of Option to Extend. Notwithstanding anything in the Sublease to the contrary, the provisions of Section 7 of the Original Sublease are hereby deemed null and void and of no further force or effect. Sublessee has no additional rights to extend the Term.

 

5. Security Deposit. Sublessor acknowledges that it is currently holding a Security Deposit with respect to the Sublease in the amount of $206,976.00. Sublessor and Sublessee acknowledge and agree that Sublessor shall continue to hold the Security Deposit in accordance with the terms and provisions of the Sublease.

 

6. Broker. The parties hereto represent and warrant to each other that neither party dealt with any broker or finder in connection with the consummation of this Amendment other than Jones Lang LaSalle Brokerage Inc. on behalf of Sublessor and Jones Lang LaSalle Brokerage Inc. on behalf of Sublessee (collectively, “Broker”), and each party agrees to protect, defend, indemnify, hold and save the other party harmless from and against any and all claims or liabilities for any brokerage commissions or finder’s fees arising out of their acts in connection with this Amendment to anyone other than the Broker. The provisions of this Section shall survive the expiration or earlier termination of the Sublease. The commissions or fees payable to the Broker shall be paid by Sublessor according to the terms of a separately executed agreement.

 

7. Miscellaneous.

 

(a) This Amendment and Sublessor’s and Sublessee’s obligations hereunder are expressly conditioned upon the execution by Landlord of a written consent to this Amendment in form reasonably acceptable to Sublessor and Sublessee (the “Consent”). In the event a Consent is not fully executed and delivered within sixty (60) days after the date of this Amendment, Sublessor and Sublessee shall each have the right to cancel this Amendment by giving written notice of such cancellation to the other party at any time after such sixty (60) day period and prior to receipt of the fully executed Consent.

 

2

 

 

(b) This Amendment sets forth the entire agreement between the parties with respect to the matters set forth herein. There have been no additional oral or written representations or agreements.

 

(c) Except as herein modified or amended, the provisions, conditions and terms of the Original Sublease shall remain unchanged and in full force and effect.

 

(d) In the case of any inconsistency between the provisions of the Original Sublease and this Amendment, the provisions of this Amendment shall govern and control.

 

(e) Submission of this Amendment by Sublessor is not an offer to enter into this Amendment but rather is a solicitation for such an offer by Sublessee. Sublessor shall not be bound by this Amendment until Sublessor has executed and delivered the same to Sublessee.

 

(f) Capitalized terms used in this Amendment shall have the same definitions as set forth in the Original Sublease to the extent that such capitalized terms are defined therein and not redefined in this Amendment.

 

(g) Each signatory of this Amendment represents hereby that he or she has the authority to execute and deliver the same on behalf of the party hereto for which such signatory is acting.

 

(h) This Amendment may be executed in one or more counterparts, each of which will be deemed an original but all of which together will constitute one and the same instrument. Counterparts of this Amendment signed and transmitted by digital or electronic means shall bind the party so signing with the same effect as though the signatures were an original signature. All signing parties consent to the use of electronic signatures on this document and agree that (i) any electronic signatures appearing thereon are the same as handwritten signatures for the purposes of validity, enforceability and admissibility; and (ii) that any electronically signed copy of this document shall, for all purposes, be deemed to be “written” or “in writing,” to have been executed, and to constitute an original written record when printed, and shall be fully admissible in any legal proceeding. For purposes hereof, “electronic signature” shall have the meaning set forth in the Uniform Electronic Transactions Act, as the same may be amended from time to time.

 

[SIGNATURES ARE ON FOLLOWING PAGE]

 

3

 

 

IN WITNESS WHEREOF, Sublessor and Sublessee have duly executed this Amendment as of the Amendment Effective Date.

 

  SUBLESSOR:
   
  TURO INC., a Delaware corporation
   
  By: /s/ Charles Fisher
  Name:   Charles Fisher
  Title: CFO
    10/31/2023
   
  SUBLESSEE:
   
  AUGMEDIX OPERATING CORP., a Delaware corporation
   
  By: /s/ Manny Krakaris
  Name:  Manny Krakaris
  Title: CEO
    10/30/2023

 

 

4

 

EX-101.SCH 3 augx-20231031.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 augx-20231031_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 augx-20231031_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Oct. 31, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 31, 2023
Entity File Number 001-40890
Entity Registrant Name AUGMEDIX, INC.
Entity Central Index Key 0001769804
Entity Tax Identification Number 83-3299164
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 111 Sutter Street
Entity Address, Address Line Two Suite 1300
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94104
City Area Code 888
Local Phone Number 669-4885
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol AUGX
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
XML 7 ea187793-8k_augmedix_htm.xml IDEA: XBRL DOCUMENT 0001769804 2023-10-31 2023-10-31 iso4217:USD shares iso4217:USD shares 0001769804 false 8-K 2023-10-31 AUGMEDIX, INC. DE 001-40890 83-3299164 111 Sutter Street Suite 1300 San Francisco CA 94104 888 669-4885 false false false false Common Stock, $0.0001 par value per share AUGX NASDAQ true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://augmedix.com/role/Cover Cover Cover 1 false false All Reports Book All Reports augx-20231031.xsd augx-20231031_lab.xml augx-20231031_pre.xml ea187793-8k_augmedix.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea187793-8k_augmedix.htm": { "nsprefix": "AUGX", "nsuri": "http://augmedix.com/20231031", "dts": { "schema": { "local": [ "augx-20231031.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "augx-20231031_lab.xml" ] }, "presentationLink": { "local": [ "augx-20231031_pre.xml" ] }, "inline": { "local": [ "ea187793-8k_augmedix.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://augmedix.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-10-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea187793-8k_augmedix.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-10-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea187793-8k_augmedix.htm", "first": true, "unique": true } } }, "tag": { "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://augmedix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001213900-23-083868-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-083868-xbrl.zip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